1248 Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.39M Hold
1,515
0.65% 22
2025
Q4
$1.63M Hold
1,515
0.87% 16
2025
Q3
$1.16M Sell
1,515
-439
-22% -$327K 0.65% 18
2025
Q2
$1.52M Buy
1,954
+24
+1% +$18.6K 0.56% 28
2025
Q1
$1.59M Sell
1,930
-21
-1% -$17.5K 0.68% 23
2024
Q4
$1.51M Buy
+1,951
New +$1.62M 0.65% 27

Other funds holding LLY

1248 Management's LLY Position: Q1 2026 in Review

1248 Management held its Eli Lilly (LLY) position steady in Q1 2026 at 1,515 shares worth $1.39M. The position accounts for 0.65% of the portfolio, ranked #22.

1248 Management first reported a position in LLY in Q4 2024 and has held it in 6 quarters since. The position peaked at $1.63M in Q4 2025. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • 1248 Management held 1,515 shares of Eli Lilly worth $1.39M as of Q1 2026.
  • 1248 Management left its Eli Lilly share count unchanged in Q1 2026.
  • Eli Lilly made up 0.65% of 1248 Management's portfolio in Q1 2026, its #22 holding.
  • 1248 Management first reported a position in Eli Lilly in Q4 2024 and has held it in 6 quarters since.
  • 1248 Management's Eli Lilly position peaked at $1.63M in Q4 2025.
  • 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on 1248 Management's 13F filing for Q1 2026, filed 15 May 2026.